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Primary  eccrine  carcinomas  of  the  eyelid  are  rare.  There
are  three  types  of  carcinomas:  mucinous,  adenoid  cystic,
and  ductal.1--5 Ductal  carcinomas  are  classiﬁed  into  two
subtypes:  signet  ring  carcinoma  (well-differentiated)  and
histiocytoid  type  (poorly-differentiated).1--3,5 Primary  histi-
ocytoid  eccrine  sweat  gland  carcinoma  of  the  eyelid  is  very
rare  and  so  far  13  cases  have  been  reported.1--3,5--7
This  kind  of  carcinoma  involves  the  dermis  and  subcutis  of
the  eyelid  and  has  often  been  misinterpreted  as  an  inﬂam-
matory  process.1,5 It  occurs  in  the  eyelid  of  the  elderly  in
one  side.1,2,7 This  is  the  ﬁrst  report  of  conﬁrmed  bilateral
histiocytoid  eccrine  sweat  gland  carcinoma.
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n  80  years  old  man  was  referred  to  the  ophthalmology
epartment  with  an  inﬂammation  of  the  left  lower  eyelid
hat  had  developed  at  the  beginning  of  2009.  A  computed
omography  (CT)  without  contrast  enhancement  showed
ncreased  thickness  of  the  upper  and  lower  eyelids  up  to
--10  mm  with  abnormal  soft  tissue  mass  in  the  upper-medial
art  of  the  left  orbit.  For  two  months  the  patient  had  expe-
ienced  a  slowly  growing  tumor  and  inﬁltration  of  the  left
ower  eyelid.  The  skin  of  the  involved  area  seemed  ery-
hematous  and  asymptomatic.  A  biopsy  of  the  thickened
rea  showed  a  benign  process  with  ﬁbroblasts  cells  inﬁltra-
ion.  Chest  X-ray  and  abdominal  ultrasound  were  normal.
 standard  local  and  oral  anti-inﬂammatory  treatment  with
rednizone  20  mg  daily  and  dexamethasone  eye  drops  two
imes  daily  was  prescribed.  During  the  two  months,  the
atient  had  experienced  a  slowly  growing  tumor  and  inﬁl-
ration  of  the  left  lower  eyelid.  The  skin  of  the  involved
rea  appeared  erythematous  and  asymptomatic.  An  open
iopsy  was  then  performed,  showing  a  benign  process-
euronaevus.  In  the  following  two  months,  the  left  lower
rasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. This is
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Figure  1  Histopathology  and  immunohistochemical  stain,  histiocytoid  eccrine  carcinoma:  (A),  cords  and  small  nests  of  histiocytoid
cells; tumor  cells  are  positive  for  cytokeratins  (B)  and  negative  for  synaptophysin  (C),  tumor  cells  are  S-100  positive  (D),  some  cells
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histopathologically  with  inﬂammatory  processes  or  withre GFAP  positive  (E),  and  cords  of  histiocytoid  cells  are  separa
yelid  showed  increased  diffuse  thickening.  A  control  CT
resented  thickness  of  the  left  lower  eyelid  of  7  mm  and
bnormal,  and  15--10  mm  of  soft  tissue  in  the  left  orbit  at  the
ame  location  as  the  previous  CT.  A  complete  excision  of  the
eft  lower  eyelid  with  reconstruction  was  done.  Histopatho-
ogical  examination  under  microscope  determined  that
here  were  cords  of  neoplastic  cells,  which  were  found
etween  muscle  ﬁbers.  The  tumor  cells  had  small  vacuoles
ithin  the  cytoplasm.  There  was  mild  pleomorphism  of  cell
uclei;  in  some  nuclei,  vesicles  were  observed.  The  tumor
ells  were  positive  for  cytokeratins  and  S-100  protein  and
egative  for  synaptophysin.  GFAP  immunostaging  gave  arti-
cial  results.  Morphology  and  clinical  data  were  consistent
ith  diagnosis  of  histiocytoid  eccrine  carcinoma  (Fig.  1).
he  patient  was  admitted  for  oncologic  treatment.  45  Gy  of
ntensity-modulated  radiation  therapy  (IMRT)  were  admin-
stered.  Several  weeks  after  radiotherapy,  it  was  observed
n  increased  diffuse  thickening  of  the  upper  and  lower
yelids  and  the  ptosis.  Magnetic  resonance  imaging  (MRI)
nd  CT  showed  inﬁltration  of  both  eyelids  and  orbit  with
xtraocular  muscles  involvement.  A  second  large  biopsy  was
one.  The  histopathology  examination  revealed  histiocytoid
ccrine  carcinoma  (Fig.  1).  Orbital  exenteration  and  wide
xcision  was  performed  at  the  Department  of  Otolaryngol-
gy  and  Laryngological  Oncology.  A  follow-up  with  positron
mission  tomography  (PET/CT)  scan,  MRI,  and  bone  scintig-
aphy  showed  no  recurrences  (Fig.  2).  After  24  months  of
nitial  treatment,  the  patient  started  to  suffer  from  inﬂam-
ation  and  edema  on  the  right  eyelid  (Fig.  3).  CT  and  MRI  of
he  right  orbit  showed  increased  thickness  of  the  upper  and
b
n
dmuscle  ﬁbers  (F).
ower  eyelids  with  orbital  involvement.  A  biopsy  of  the  eye-
ids  showed  the  same  type  of  pathology  previously  diagnosed
n  the  left  eye  (histiocytoid  eccrine  carcinoma;  Fig.  1).  The
atient  was  admitted  for  oncologic  treatment.  An  E9MeV,
5  Gy  radiotherapy  was  administered.  Two  years  later,  the
atient  is  alive  without  evidence  of  recurrence  or  metastatic
isease.
iscussion
he  histology  of  ductal  adenocarcinoma  of  the  breast,
ccrine  sweat  glands,  and  lacrimal  or  salivary  gland  adeno-
arcinoma  may  be  identical.1--4,8 The  histogenesis  of  primary
utaneous  histiocytoid  sweat  gland  carcinoma  remains
ontroversial.4,5 The  exclusive  location  in  the  axilla  and  eye-
id  with  cutaneous  areas  containing  apocrine  glands  supports
ts  apocrine  differentiation.5,9
The  diagnosis  of  primary  histiocytoid  variant  of  eccrine
weat  gland  carcinoma  is  sometimes  difﬁcult;  immuno-
istochemical  staining  for  CEA,  cytokeratins,  epithelial
embrane  antigen,  and  others,  are  still  used.3,4 Usually,
his  type  of  carcinoma  involves  the  dermis  and  subcutis
f  the  eyelid  but,  occasionally,  it  can  be  observed  in
he  orbit  or  inﬁltrate  the  orbit.3,10 The  neoplastic  cells
nvolve  the  dermis  of  the  eyelid  and  are  often  mistakenenign  neoplasms,  such  as  granular  cell  tumor,  melanocytic
evus,  or  neuronevus.1,5,6 In  some  cases,  it  could  delay  the
iagnosis  and  lead  to  slow  or  fast  growth  of  the  tumor
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Figure  2  Magnetic  resonance  imaging  scan:  left  orbit  after  exenteration  without  pathologic  enhancement,  mucus  ﬂuid  in  left
maxillary sinus-frontal  and  plain  projection  (A  and  B).  Bone  scintigraphy,  multiple  intense  enhancement  in  left  orbit,  and  bony
skeleton due  to  metabolic  and  postoperative  changes  (C).
 radi
iFigure  3  Patient  two  years  after  left  orbit  exenteration  and
skin and  eyelids,  frontal  and  lateral  view  (A  and  B).
and  spread  of  the  disease,  as  observed  in  the  present
case.The  typical  clinical  ﬁndings  are  progressive  painless  inﬁl-
tration  of  both  eyelids  or  growth  starting  in  one  eyelid,  later
involving  the  other.  The  inﬁltration  of  the  eyelids  results
c
g
a
fotherapy;  the  second  tumor  is  inﬁltrating  the  right  periorbital
n  an  monocle-like  appearance.2,3,5,7,9 Diagnosis  arises  from
areful  CT  and  MRI  of  the  orbit  and  proper  histologic  investi-
ation.  In  case  of  suspicion  of  misdiagnose,  secondary  biopsy
nd  scans  should  be  performed  immediately.  Histologic  dif-
erential  diagnosis  includes  cutaneous  neoplasms  that  may
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10. Khalil M, Brownstcin S, Codere F, Nicolle D. Eccrine sweat gland
carcinoma of the eyelid with orbital involvement. Arch Ophthal-
mol. 1980;98:2210--4.ARTICLE
 
ontain  signet  ring  cells,  such  as  basal  and  squamous  cell
arcinoma,  melanocytic  tumors,  cylindroma  or  lymphoma,
hich  are  consistent  with  eyelid  development.5,8
Treatment  of  primary  histiocytoid  eccrine  sweat  gland
arcinoma  of  the  eyelid  requires  excision  with  wide
argins  and  sometimes  orbital  exenteration.5 Adjuvant
herapy  includes  radiotherapy  and  chemotherapy  with
-ﬂuorouracil.5,7 In  some  cases,  a  rapid  progression  of
he  tumor  after  surgical  resection  can  be  observed.1 The
ame  situation  can  occur  after  radiotherapy  alone.  In  the
resent  case,  the  tumor  was  unresponsive  to  radiother-
py  and  continued  to  grow.  A  wide  excision  with  orbital
xenteration  and  postsurgical  radiotherapy  was  performed,
hich  was  useful  for  local  control.  Unfortunately,  a  second
rimary  histiocytoid  eccrine  sweat  gland  carcinoma  of
he  right  eyelid  was  diagnosed.  At  that  time,  the  tumor
as  successfully  treated  with  radiotherapy.  It  is  unknown
hether  the  second  malignancy,  after  two  years,  was
adiotherapy-dependent  or  unrelated.
The  clinical  course  of  primary  histiocytoid  eccrine  sweat
land  carcinoma  is  usually  protracted  for  several  years.9
ecurrences  can  be  expected  and  metastases  can  reach
ymph  nodes,  parotid  gland,  skin,  lung,  or  liver.4,5,7,9 To  the
est  of  the  authors’  knowledge,  this  is  the  ﬁrst  case  of  bilat-
ral  histiocytoid  variant  of  eccrine  sweat  gland  carcinoma
f  eyelids.
onclusions
arly  diagnosis  is  paramount  in  histiocytoid  eccrine  sweat
land  carcinoma  of  the  eyelid.  Radical  surgery  is  the  ﬁrst
hoice  treatment.  A  long  follow-up  is  recommended,  and
ilateral  involvement  is  possible.onﬂicts of interest
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